Renhe Pharmaceutical (000650): The pharmaceutical sector is under short-term pressure, and the health products sector is growing steadily
Renhe Pharmaceutical (000650) Announcement Review: The results of the combined three-quarter report of the Health Business exceeded market expectations
Renhe Pharmaceutical (000650): The 21-year mid-year report released, the traditional business grew steadily, and the health business is expected to be merged with H2
Renhe Pharmaceutical Co., Ltd. (000650): "track + Channel" Pharmaceutical Cosmetic Business develops rapidly, grows at a high speed and is sustainable.
Renhe Pharmaceutical (000650): the big health business with make-up as the core is expected to develop rapidly.
Renhe Pharmaceutical (000650): announcement of acquisition intention Agreement Transformation and healthy Future
Renhe Pharmaceutical (000650): quarterly report released net profit increased by 45.38% compared with the same period last year.
Renhe Pharmaceutical (000650): the rapid growth of OME products continues the trend of improvement.
Renhe Pharmaceutical (000650): high performance growth and continuous creation of gold products to enhance profitability
Renhe Pharmaceutical (000650): continuous performance, gradual cashing of valuation, room for improvement.
Renhe Pharmaceutical (000650): slightly higher-than-expected cash flow fluctuations are caused by the business cycle
仁和药业(000650):一季度业绩发布 归母净利润同比增长34%
仁和药业(000650):自产品占比提升 大品种战略推动业务发展
Renhe Pharmaceutical (000650): Impairment of goodwill drags down profits and OTC revenue grows rapidly
Renhe Pharmaceutical (000650) Quarterly Report Review: Outstanding Performance in the First Three Quarters, Optimizing Sales Varieties to Create Gold Products
Renhe Pharmaceutical (000650) Third Quarterly Report Tracking: Performance Growth Exceeds Expectations and Continues to Focus on Recommendations
Renhe Pharmaceutical (000650) Quarterly Report Review: Business Maintains Rapid Growth, Financial Metrics Remain Good
Renhe Pharmaceutical (000650) Quarterly Report Review: Performance Meets Expectations of Improved Revenue Growth Rate in 18Q4
Renhe Pharmaceutical (000650) Third Quarter Results Forecast Review: Performance Growth Exceeds Expectations and Continues to Focus on Recommendations
Renhe Pharmaceutical (000650) Announcement Comment: Three Quarterly Report Announces Continued Rapid Growth in Performance
No Data